Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
- PMID: 30359249
- PMCID: PMC6202883
- DOI: 10.1186/s12885-018-4970-9
Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
Abstract
Objectives: Among women with epithelial ovarian cancer (EOC), histotype is one of the major prognostic factors. However, few data are available on histotype- specific survival and mortality estimates among these patients. We therefore examined survival and causes of death among women with EOC by histotype.
Methods: A population- based cohort including all ovarian cancer patients diagnosed in British Columbia (BC) between 1990 and 2014 was built using population-based administrative datasets. We compared causes of death within histotypes, by age at diagnosis, BRCA status, and time since diagnosis.
Results: A total of 6975 women were identified as having been diagnosed with EOC between 1990 and 2014 in BC. The most common cause of death among these women was ovarian cancer until 10 years post diagnosis when other causes surpassed ovarian cancer as the leading cause of death. Among women with serous EOCs, ovarian cancer was the leading cause of death 12 years after diagnosis, whereas ovarian cancer was the leading cause of death for 8 years among women with non- serous EOCs. Among women with serous EOCs, ovarian cancer was the leading cause of death for 12 years among younger women (< 60 years of age) compared to 8 years among women > = 60 years of age, and those with BRCA mutations were more likely to die from ovarian cancer than those without a BRCA mutation.
Conclusions: Within 10 years from diagnosis, ovarian cancer is the leading cause of death among women diagnosed with EOC.
Keywords: Histotype; Mortality; Ovarian Cancer; Survival.
Conflict of interest statement
Ethics approval and consent to participate
The University of British Columbia’s behavioural research ethics board has approved the study. As the data linkage maintained patient anonymity (all identifiers were removed before being provided to the researchers) and the population-based administrative datasets in BC operate based on passive consent (i.e. patients may withdraw their consent and their data will be removed from the administrative datasets), direct patient consent was not required.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014 - Special Topic: Skin Cancers. Canadian Cancer Society; 2014. http://www.cancer.ca/. Accessed 20 May 2017.
-
- Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2016 - Special topic: HPV-associated cancers; 2016. http://www.cancer.ca/. Accessed 20 May 2017.
-
- Nuttall R. Canadian cancer statistics 2017. Canadian Cancer Society; 2017. http://www.cancer.ca/. Accessed 20 July 2017.
-
- Dinkelspiel Helen E., Champer Miriam, Hou June, Tergas Ana, Burke William M., Huang Yongmei, Neugut Alfred I., Ananth Cande V., Hershman Dawn L., Wright Jason D. Long-term mortality among women with epithelial ovarian cancer. Gynecologic Oncology. 2015;138(2):421–428. doi: 10.1016/j.ygyno.2015.06.005. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
